Latest news with #JohnDuffy
RNZ News
2 days ago
- Business
- RNZ News
Coalition accepts Consumer NZ's 'Price it Right' supermarket petition
In 2024, the Commerce Commission estimated pricing errors were likely costing shoppers tens of millions of dollars a year. (File photo) Photo: supplied Economic Growth Minister Nicola Willis has accepted Consumer New Zealand's 'Price It Right' petition for accurate supermarket pricing . The petition, signed by 25,000 people, was presented to Willis on the steps of Parliament this morning. Willis wrote to the major supermarkets in June, warning them against misleading promotional practices and pricing errors. Consumer NZ chief executive John Duffy said supermarkets had had plenty of opportunity to sort it out for themselves. "It's time for the government to step in and make supermarkets price it right, and tens of thousands of New Zealanders agree. "People want clear pricing rules, automatic compensation and stronger penalties when supermarkets get it wrong." In 2024, the Commerce Commission estimated pricing errors were likely costing shoppers tens of millions of dollars a year. "If supermarkets can't get their pricing right, they - rather than shoppers - should face the consequences," Duffy said. Consumer NZ's petition asked the government to introduce a mandatory supermarket pricing accuracy code: "We know that all the problems in the supermarket sector won't be fixed overnight, but new rules like those in our proposed code will help put money back in the pockets of New Zealanders," Duffy said. Willis told RNZ she had received assurances new processes were in place after putting major supermarkets on notice in June. Finance Minister Nicola Willis said the government would hold supermarkets accountable. (File photo) Photo: RNZ "They then wrote back to me and pledged that they are going to have refund policies in place from now on, in the case of Foodstuffs that hadn't previously been the case. "Now, if a pricing error is found, you get your money back and you keep to you get to keep the goods. "They've also pledged that they will advertise these refund policies and they have pledged that they are investing significant sums and better training for their staff and better systems to stop these errors happening in the first place." Willis said they were important commitments and the government would hold major supermarkets accountable to them. "I have been consulting on strengthening the infringement regime in the Fair Trading Act, strengthening penalties and potentially introducing civil proceedings so that it is easier to prosecute supermarkets when they do the wrong thing," she said. "I will consider the submissions on that consultation before taking recommendations to Cabinet." Asked if it was fair the onus was still on consumers to notice price discrepancies, Willis said it wasn't. "I do worry that for every person who's noticed it, there are other New Zealanders who've been ripped off and haven't had the opportunity to get redress. "So that's why we are strengthening our approach in this area, we think it's time that the supermarkets pulled up their socks." Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Yahoo
03-06-2025
- Business
- Yahoo
Quantum BioPharma Clarifies It Has Not Changed Its Name
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ('Quantum BioPharma'), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces its response to information about certain stock trading platforms as well as misinformation being circulated on certain social media channels. Certain stock trading platforms mistakenly have the Quantum BioPharma name changed to Unbuzzd Wellness Inc. (formerly, Celly Nutrition Corp.) after the news release was issued on May 29, 2025. Quantum BioPharma has not changed its name. In addition, it has been brought to the attention of Quantum BioPharma that misinformation is being circulated on certain social media channels that Unbuzzd Wellness Inc., the company behind unbuzzd™, the scientifically-proven product that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms, is doing a reverse takeover transaction ('RTO') into Quantum BioPharma. Currently Unbuzzd Wellness Inc. is not doing a RTO transaction with Quantum BioPharma. Unbuzzd Wellness Inc. has hired leading audit firm MNP LLP ('MNP') effective May 20, 2025, to conduct Public Company Accounting Oversight Board ('PCAOB') audits of the Company's financial statements in preparation for a possible initial public offering ('IPO'). MNP, registered with the PCAOB, has the experience and proven track record to deliver audits of the highest standard. Hiring MNP follows the Company's announcement on February 5, 2025, regarding their retention of a New York investment bank to advise on a capital raise and explore an IPO, pending regulatory approval. Financial terms between Quantum BioPharma and Unbuzzd Wellness Inc. Currently Quantum BioPharma is the largest shareholder and debt holder of Unbuzzd Wellness Inc. Pursuant to the terms of their Agreement, Quantum will receive a 7% royalty on revenue from Unbuzzd Wellness Inc., until a total in the amount of $250,000,000 has been paid to Quantum, at which point the rate is reduced to 3%. In addition, Unbuzzd Wellness Inc. had issued Quantum 200,000,000 post-split common shares in the capital of the Unbuzzd Wellness Inc. ('Common Shares') as a licence fee and has issued Quantum an anti-dilution warrant, entitling Quantum to exercise the warrant any point in the next three years to increase their holding in the company to 25% for nominal consideration. On a go-public transaction, Quantum BioPharma will own at least 25% of Unbuzzd Wellness Inc. Unbuzzd Wellness Inc. and Quantum entered into a loan agreement, whereby Quantum loaned the Company $1,300,000 on secured basis with a term of 3 years, which will bear interest at a rate of 10% per annum, payable on each anniversary. Unbuzzd Wellness Inc.'s leadership team brings unparalleled experience and expertise to the table. The company is led by CEO John Duffy, a seasoned executive with a distinguished career at Coca-Cola Enterprises and The Coca-Cola Company. Duffy's vision is further complemented by the strategic guidance of beverage industry luminary and Unbuzzd Wellness Inc. Board Co-Chair Gerry David, the former CEO of Celsius Holdings, Inc., who played a pivotal role in establishing Celsius as a leading name in the beverage industry. Debt Settlement The Company also announces an authorized debt settlement for two vendors totaling USD$20,930 with Class B Shares that the board of directors of the Company (the "Board") authorized. The Company intends to complete the Debt Settlements in or around the first week of June 2025. About Quantum BioPharma Ltd. Quantum BioPharma (NASDAQ: QNTM) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. ('Lucid'), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented unbuzzd™ and spun out its OTC version to a company, Unbuzzd Wellness Inc. (formerly Celly Nutrition Corp.), led by industry veterans. Quantum BioPharma retains ownership of 20.11% (as of March 31, 2025) of Unbuzzd Wellness Inc. The agreement with Unbuzzd Wellness Inc. also includes royalty payments of 7% of sales from unbuzzd™ until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property. For more information on Quantum BioPharma, please visit About Unbuzzd Wellness Inc. The Company, a non-trading but fully reporting public issuer, stands as a pioneering force in the wellness and recovery supplement landscape. unbuzzd has been developed by a world-class research and development team in pharmacology and medicine, with a commitment to innovation and quality. With a proprietary blend of vitamins, minerals and herbs, unbuzzd helps your body process alcohol faster, restore mental alertness, and improve cognition so you can drink responsibly. unbuzzd appeals to a broad audience of alcohol consumers who want to have a good time, be in control, and still feel great the next day. Scientifically-backed by a recently completed double-blind, randomized, placebo-controlled crossover design clinical trial, unbuzzd dramatically accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, restores mental clarity, and reduces the symptoms of intoxication, impairment and hangover. The full press release of the clinical trial can be found here. unbuzzd ready-to-mix powder sticks are available in 3-pack, 8-pack, and 18-pack formats at and unbuzzd is a registered trademark of the Company. Individual results may vary. unbuzzd is a dietary supplement. Consuming unbuzzd after alcohol ingestion does not permit you to operate a vehicle. Drink responsibly. DO NOT DRINK AND DRIVE. For more information on Unbuzzd Wellness Inc. please visit Forward-Looking Information Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include statements related to such. Forward-looking information in this press release are based on certain assumptions and expected future events. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to additional information relating to Quantum BioPharma, including its annual information form, can be located on the SEDAR+ website at and on the EDGAR section of the United States Securities and Exchange Commission's website at for a more complete discussion of such risk factors and their potential effects. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward- looking information, except as required by applicable law. Contacts: Quantum BioPharma Ltd. Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board Email: Zsaeed@ (833) 571-1811 Investor Relations Investor Relations: IR@ Inquiries: info@
Associated Press
29-05-2025
- Business
- Associated Press
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.
TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ('Quantum BioPharma'), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that Unbuzzd Wellness Inc. (formerly, Celly Nutrition Corp.) (the 'Company'), the company behind unbuzzdTM, the scientifically-proven beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms, that it has hired leading audit firm MNP LLP ('MNP') effective May 20, 2025, to conduct Public Company Accounting Oversight Board ('PCAOB') audits of the Company's financial statements in preparation for a possible initial public offering ('IPO'). The Company's predecessor auditor, Stern & Lovrics LLP (the 'Predecessor Auditor') resigned effective May 20, 2025, at the Company's request, and the Company's board of directors, upon the audit committee's recommendation, appointed MNP to fill the resulting vacancy until the close of the next annual meeting of the Company's shareholders. MNP, registered with the PCAOB, has the experience and proven track record to deliver audits of the highest standard. Hiring MNP follows the Company's announcement on February 5, 2025, regarding their retention of a New York investment bank to advise on a capital raise and explore an IPO, pending regulatory approval. John Duffy, CEO of Unbuzzd Wellness Inc. stated, 'This engagement of audit firm MNP demonstrates that we adhere to the highest standards in the industry. MNP has worked hard to understand our business and their PCAOB-level audits will prepare Unbuzzd Wellness for a possible IPO.' Mr. Duffy has more than two decades of experience in leadership positions in the beverage industry, including as former VP of Marketing Assets and VP of National Sales at Coca-Cola.' Gerry David, Board Co-Chair and former CEO of Celsius Holdings with their bestselling energy drink Celsius Energy, added, 'Completing our PCAOB audits with MNP represents another important step in ensuring our continued success and strength as we raise capital and consider the possibility of an IPO.' The change of auditor notice required pursuant to National Instrument 51-102 – Continuous Disclosure Obligations ('NI 51-102') and associated material have been filed on SEDAR+ ( under the Company's profile within the prescribed time period. There were no reservations or modified opinions in any auditor's reports nor any reportable events as defined in NI 51-102 in connection with the audits by the Predecessor Auditor of the Company's most recently completed financial year or any subsequent period. Name Change In addition, the Company has changed its name to 'Unbuzzd Wellness Inc.' effective May 23, 2025 (the 'Name Change'). The board of directors of the Company approved the Name Change in accordance with the articles of the Company. The Company's new CUSIP is 90429T100 and its new ISIN is CA90429T1003. Shareholders are not required to exchange existing share certificates for new share certificates bearing the Company's new name. The Name Change does not affect the rights of the Company's shareholders and no further action is required by existing shareholders. About Quantum BioPharma Ltd. Quantum BioPharma (NASDAQ: QNTM) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. ('Lucid'), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented unbuzzd™ and spun out its OTC version to a company, Unbuzzd Wellness Inc. (formerly Celly Nutrition Corp.), led by industry veterans. Quantum BioPharma retains ownership of 20.11% (as of March 31, 2025) of Unbuzzd Wellness Inc. The agreement with Unbuzzd Wellness Inc. also includes royalty payments of 7% of sales from unbuzzd™ until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property. For more information on Quantum BioPharma, please visit About Unbuzzd Wellness Inc. The Company, a non-trading but fully reporting public issuer, stands as a pioneering force in the wellness and recovery supplement landscape. unbuzzd has been developed by a world-class research and development team in pharmacology and medicine, with a commitment to innovation and quality. With a proprietary blend of vitamins, minerals and herbs, unbuzzd helps your body process alcohol faster, restore mental alertness, and improve cognition so you can drink responsibly. unbuzzd appeals to a broad audience of alcohol consumers who want to have a good time, be in control, and still feel great the next day. Scientifically-backed by a recently completed double-blind, randomized, placebo-controlled crossover design clinical trial, unbuzzd dramatically accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, restores mental clarity, and reduces the symptoms of intoxication, impairment and hangover. The full press release of the clinical trial can be found here. unbuzzd ready-to-mix powder sticks are available in 3-pack, 8-pack, and 18-pack formats at and unbuzzd is a registered trademark of the Company. Individual results may vary. unbuzzd is a dietary supplement. Consuming unbuzzd after alcohol ingestion does not permit you to operate a vehicle. Drink responsibly. DO NOT DRINK AND DRIVE. For more information on Unbuzzd Wellness Inc. please visit Forward-Looking Information Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as 'may', 'should', 'anticipate', 'expect', 'potential', 'believe', 'intend' or the negative of these terms and similar expressions. Forward-looking statements in this news release include statements related to such. Forward-looking information in this press release are based on certain assumptions and expected future events. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to additional information relating to Quantum BioPharma, including its annual information form, can be located on the SEDAR+ website at and on the EDGAR section of the United States Securities and Exchange Commission's website a more complete discussion of such risk factors and their potential effects. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those Quantum BioPharma Ltd. Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board Email: [email protected] Telephone: (833) 571-1811 Investor Relations Investor Relations: [email protected] General Inquiries: [email protected]
CBC
26-04-2025
- Politics
- CBC
A consequential election ends with a stark choice and an uncertain future
Social Sharing John Duffy, the late political strategist and author, began Fights of Our Lives, his lively and encyclopedic account of the federal campaigns that shaped this country, with a simple premise — one always worth returning to at moments like this. "Elections matter," he wrote. Writing in 2002, Duffy was pushing back against what he saw as the lazy cynicism of "academics, journalists and political dissenters of various stripes" who had "worked very hard for many years to convince voters in democracies that elections are inconsequential or, even worse, rigged, so that this or that social group maintains dominance no matter what happens at the polls." Duffy's view was that elections — fundamentally human endeavours — are precarious and dynamic, and the choices that leaders and voters make are consequential. If anything, the last decade of global politics has made it much harder to be complacent. With the future of Western democracy newly uncertain, the climate crisis bearing down and polarization on the rise, it can now feel like elections almost matter too much. In Canada, even before this spring, the notion that any given election was possibly the "most important" to have ever occurred was in some danger of becoming a cliché. But it is at least much harder to dispute this time. "We are facing the most significant crisis of our lifetimes," Liberal Leader Mark Carney said at Rideau Hall last month, moments after asking the governor general to trigger this election. Two weeks later, former prime minister Stephen Harper appeared at a rally in Edmonton with Pierre Poilievre and thanked Conservative supporters for being a "positive part of the most important decision that this country is going to make in decades." Not to be outdone, former Reform Party leader Preston Manning emerged mid-campaign to warn that, above and beyond everything else, the unity of the country hung in the balance — and that a Liberal victory would drive Western provinces to secede. Carney has stated repeatedly that this is the "most consequential election of our lifetime." That is perhaps a judgment that can only truly be made in hindsight, once the exact consequences are known. But given the choices and the circumstances, it certainly seems possible that the 45th general election will come to deserve that title. Stewart Prest, a political scientist at the University of British Columbia, wrote this week that Canada's domestic challenges are "multiple and significant." But from watching the leaders' debates last week, Prest said it was clear that "Canadian voters, journalists, debate moderators and politicians alike are all still coming to terms with the depth of change in the world around them." That is almost certainly true. But this campaign was probably only ever going to be about Canadians starting to wrap their minds around the challenges in front of them — and, crucially, choosing who will lead the country's initial response. Unlike the "free trade election" of 1988 — the last time Canada's relationship to the United States was so central to a federal election — this one is perhaps less easily reduced to a yes-or-no question on a specific, tangible thing. While it may come to be remembered as the "Donald Trump election," this vote concerns a stack of questions about how and what Canada should be at the start of this new epoch. 2 very different candidates for prime minister It has been noted that, on some matters, the difference between the two leading parties has shrunk over the course of the last two months. Carney has abandoned the federal government's carbon tax, nixed planned changes to capital gains taxes and opened the door to approving new pipelines to transport oil and gas. The Liberals and Conservatives agree on the need to impose retaliatory tariffs on American products in response to President Donald Trump's tariffs on Canadian products. The two parties are proposing broadly similar increases in defence spending. They are both promising income tax cuts. They would both hope to use federal spending power to persuade municipalities to eliminate regulatory barriers to housing construction. But the Liberal and Conservative leaders still offer Canadians a stark choice of personalities, priorities and biographies. Poilievre starts from the premise that the biggest problem facing this country is the broad set of policies implemented by Justin Trudeau's government over the last nine years — and that he is the person to lead great change. Carney starts from the premise that the biggest problem facing this country is Trump and the agenda and politics that he represents — and that he is the person best suited to lead the country through this precarious moment. Poilievre, an experienced and combative parliamentarian, is a populist conservative who has promised to fight " woke ideology" and who jokes that "income tax is the fine you pay for the crime of working hard." Until recently, he seemed to be riding the wave of frustration that has toppled incumbent governments across the Western world. Carney, a former central banker but a novice politician, is a technocratic progressive who is comfortable with the word "catalyze" and who believes the government needs to "step up" and act amid the uncertainty of the present crisis. His presence has reset the political playing field, but he is still leading a party that has been in power for more than nine years. On the crisis of climate change, the two parties are possibly as far apart as they have ever been, with the Conservatives no longer committed to a target to reduce greenhouse gas emissions. With governments still struggling to contain the opioid crisis, the Conservatives would move away from the harm reduction policies the Liberals have opened the doors to, ending safer supply programs and putting new limits on supervised consumption sites. The Liberals believe a new public agency should be charged with building new affordable housing; the Conservatives believe the Liberals will only succeed in wasting more money on bureaucracy. Poilievre says he would use the notwithstanding clause to overrule judges on sentencing decisions; the Liberals argue that would set a dangerous precedent. Both parties have promised to reduce the cost of government operations, but the Liberals would be willing to run slightly higher deficits for the next four years. The Conservatives have stopped short of fully embracing Liberal-designed social programs like child care, dental care and pharmacare, saying only that they would honour "existing" agreements and coverage (only three provinces and one territory have signed pharmacare agreements with the federal government). The two parties fundamentally disagree about the future of the CBC. Both leaders broadly speak about the value of economic sovereignty, but seem to view the challenge of Donald Trump differently. Poilievre has framed the Trump challenge as a tariff fight that should end with a renegotiated trade deal (and perhaps even expanded trade with the United States). Carney frames the Trump challenge in terms of a changed relationship and a changed world which will require Canada to act differently, forge new alliances with "like-minded countries" and renegotiate its terms with the United States. Some of the difference in framing might be explained by each leader's political interests. But their different frames also speak to real choices this country will have to make in the weeks, months and years ahead about its relationship with the United States. Record 7.3M Canadians voted in advance polling. What it all means | Hanomansing Tonight 3 days ago Duration 7:07 The heavy burden of victory In an interview with National Public Radio this week, Steven Levitsky, a professor of government at Harvard, opined that Americans were "no longer living in a democratic regime." That statement might contain two warnings for Canadians — one about the immediate future of the behemoth to our south, and another about how little can be taken for granted when it comes to the health of any democracy. After five weeks of official campaigning, and four months of remarkable change, the Canadian electorate has clustered around two options. Drawn by the populist message, the conservative ideals or their unhappiness with the state of things after nine years of a Liberal prime minister, something like 38 per cent of voters seem pledged to Poilievre's Conservatives — nearly as large a share of voters as Stephen Harper's Conservatives received when they formed a majority government in 2011. Driven by concerns about Trump, opposition to Poilievre or their preference for progressive values, a little more than 40 per cent of voters are inclined to unite behind Mark Carney's Liberals — slightly more than Trudeau's Liberals received when they formed a majority government in 2015. If the polls match the result on Monday night, it would be the first time since 1957 that two parties have each received 38 per cent or more in a federal election. In that case, two-fifths of those who voted will wake up disappointed Tuesday morning. The winners will have to contend with that. Whoever is prime minister after Monday will inherit all the challenges that were present before Trump returned to the White House — from the cost of housing to the climate crisis to the opioid crisis to the various forces that threaten democracy in the 21st century — and they'll have to lead this country through a moment of incredible stress and uncertainty. They'll have to contend with a president taking unprecedented actions. The global economy may tip into a recession. The prime minister will have to make a dozen major decisions that we can currently only guess at. This moment in Canadian history has been cause for reflection and patriotism. It has inspired a competitive election and may drive a higher-than-usual rush to the polls. One way or another, the result will be consequential.
Associated Press
10-04-2025
- Business
- Associated Press
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ('Quantum BioPharma' or the 'Company'), today announced its licensee – Celly Nutrition Corporation ('Celly Nutrition'), the company behind unbuzzd™ – the beverage that accelerates alcohol metabolism, restores mental clarity, and reduces hangover symptoms – has secured a landmark partnership with the Asian American Trade Associations Council ('AATAC') to expand the retail availability of unbuzzd™, increase sales, and recruit new customers. This partnership will focus on unbuzzd™'s convenient 'On-the-Go Powder Stick Packs' which have been scientifically proven to accelerate the reduction of blood alcohol levels and restore mental alertness. AATAC is made up of smaller buying groups, regional sub-chapters, and other trade organizations that represent over 50,000 members who collectively operate more than 80,000 locations, including over half of all convenience stores across the United States and Puerto Rico. Brands in the AATAC network include 7-Eleven, Shell, Circle K, ampm, Texaco, BP, 76, Sunoco, Gulf, and Chevron, among many others. AATAC has played an important role in launching innovative new products into the retail space, many of which have reached the highest levels of retail sales in the consumer goods category. John Duffy, CEO of Celly Nutrition, stated, 'We are excited to partner with AATAC to further expand unbuzzd™'s retail presence. This collaboration provides access to top retail operators across the United States, helping to grow sales and making unbuzzd™ available to even more consumers.' Sunil Capita, National Programs Director of AATAC, added, 'The health and wellness category has grown significantly over recent years in our industry, and recovery products have become a leader within that category. Understandably, our Association wants to be at the forefront of this evolving trend, so we are very excited to see how well unbuzzd™ will perform in our retail sites. We would eventually like to see recovery products offered to U.S. consumers by thousands of our network retailers across the country.' About AATAC AATAC is a national association consisting of regional sub-chapters, smaller buying groups, independents, and trade affiliates that collectively represent over 80,000 locations across the United States. AATAC empowers its retailers by educating them on market trends and directly introducing vendor suppliers and programs that allow them to stay relevant and competitive in the industry. AATAC's DRIP program allows approved products to obtain hundreds of retail accounts within a matter of weeks. Visit for more information. About Celly Nutrition Corporation Celly Nutrition, a non-trading but fully-reporting public issuer, stands as a pioneering force in the wellness and recovery supplement landscape. unbuzzd™ has been developed by a world-class research and development team in pharmacology and medicine, with a commitment to innovation and quality. With a proprietary blend of vitamins, minerals, and herbs, unbuzzd™ helps your body process alcohol faster, restore mental alertness, and improve cognition so you can drink responsibly. unbuzzd™ appeals to a broad target audience of alcohol consumers who want to have a good time, be in control, and still feel great the next day. Scientifically backed by a recently completed double-blind, randomized, placebo-controlled crossover design clinical trial, unbuzzd™ dramatically accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, restores mental clarity, and reduces the symptoms of intoxication, impairment and hangover. The full press release of the clinical trial can be found here. unbuzzd™ ready-to-mix powder sticks are available in 3-pack, 8-pack and 18-pack formats at and unbuzzd™ is a registered trademark of Celly Nutrition Corp. Individual results may vary. unbuzzd is a dietary supplement. Consuming unbuzzd after drinking alcohol does not permit you to operate a vehicle. Drink responsibly. DO NOT DRINK AND DRIVE. About Quantum BioPharma Ltd. Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. ('Lucid'), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented UNBUZZD™ and spun out its OTC version to a company, Celly Nutrition Corp. ('Celly Nutrition'), led by industry veterans. Quantum BioPharma retains ownership of 25.71% (as of June 30, 2024) of Celly Nutrition at The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd ™ until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property. Forward-Looking Information Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as 'may', 'should', 'anticipate', 'expect', 'potential', 'believe', 'intend' or the negative of these terms and similar expressions. Forward-looking statements in this news release include statements related to such. Forward-looking information in this press release are based on certain assumptions and expected future events. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to additional information relating to Quantum BioPharma, including its annual information form, can be located on the SEDAR+ website at and on the EDGAR section of the United States Securities and Exchange Commission's website at for a more complete discussion of such risk factors and their potential effects. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward- looking information, except as required by applicable law. Contacts: Quantum BioPharma Ltd. Telephone: (833) 571-1811
